Yuhan, Chong Kun Dang and Hanmi’s outpatient prescriptions increased by over 10%

Last January, outpatient prescriptions were analyzed to record KRW 959.8 billion increased by 5.9% compared to the last year. Among the top pharmaceutical companies, moreover, Yuhan Corporation, Chong Kun Dang and Hanmi Pharm were analyzed to have a refreshing start as recording an amount increased by over 10% in the category.

According to the Shinhan Investment Corp’s analysis result of UBIST...